About 200 reports

  • INFLUENZA
  • INFLUENZA SYMPTOMS

BMC MEDICINE, ##(##), PP. ##-##.

  • Influenza
  • United States
  • Market Size
  • Sanofi S.A.
  • Seqirus UK Limited
  • Seasonal Influenza: Executive Summary
  • Risk Factors and Comorbidities for Seasonal Influenza

Table ## below outlines the risk factors and comorbidities associated with seasonal influenza.

  • Influenza
  • United Kingdom
  • United States
  • Demographic
  • Social Conditions
  • SEASONAL INFLUENZA & VACCINATION
  • 6. Global - Influenza Vaccines Brand Sales and Forecast

Indonesia ##.

  • Influenza
  • World
  • Forecast
  • Market Size
  • Sanofi S.A.
  • INFLUENZA SYMPTOMS
  • 4.1.1.1 INFLUENZA A VIRUS

ELSEVIER LTD, ##(##), PP. ##-##.

  • Influenza
  • China
  • East Asia
  • India
  • Sinovac Biotech Ltd.
  • GLOBAL LIVE ATTENUATED INFLUENZA VACCINES MARKET
  • Market definition

GLOBAL RECOMBINANT INFLUENZA VACCINES MARKET Currently, only one recombinant influenza vaccine, Flublok, is approved by the US Food and Drug Administration (FDA) for influenza.

  • Influenza
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Seqirus UK Limited
  • Seasonal Influenza: Executive Summary
  • Risk Factors and Comorbidities for Seasonal Influenza

Table ## below outlines the risk factors and comorbidities associated with seasonal influenza.

  • Influenza
  • China
  • Japan
  • Demographic
  • Forecast
  • Types of human influenza viruses
  • Global influenza immunodiagnostics market 2016-2021 ($ millions)

Global Influenza Diagnostics Market: About this market Influenza diagnostic kits are available in both rapid and conventional testing models.

  • Diagnostics
  • Influenza
  • World
  • Forecast
  • Seasonal Influenza Key Facts
  • Seasonal Influenza Development Pipeline, by Phase

Seasonal Influenza: Competitive Landscape to 2026 Report Code: GDHC##CL Published: November 2018 Healthcare TABLE OF CONTENTS ##.

  • Influenza
  • United States
  • Roche Group
  • Sanofi S.A.
  • Shionogi & Co., Ltd.
  • RIDTS FOR INFLUENZA A
  • RIDTS FOR INFLUENZA B

You can easily book an appointment with one online.

  • Influenza
  • World
  • Forecast
  • Alere Inc.
  • Quidel Corporation
  • COLD AND FLU DRUGS
  • IV.COLD AND FLU DRUGS PRODUCTION AND DEMAND

The Cold and Flu Drugs industry is one of key sectors of Chinese industry and has become more and more important.

  • Influenza
  • China
  • Sanshine Pharmaceutical Co., Ltd.
  • Tongrentang Group
  • Topsun Technology Qidong Gantianli Pharmaceutical Co., Ltd
  • COLD AND FLU DRUGS
  • Cold and Flu Drugs Companies in China

The Cold and Flu Drugs industry is one of key sectors of Chinese industry and has become more and more important.

  • Influenza
  • China
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Tongrentang Group
  • Topsun Technology Qidong Gantianli Pharmaceutical Co., Ltd
  • COLD AND FLU DRUGS EXPORT (BILLION YUAN)
  • Cold and Flu Drugs Import by Curative Effect

INTRODUCTION Chapter I Table ##: Economic Outlook Summary (Billion Yuan) Chart ##: Economic Outlook Summary (Billion Yuan) Chapter I INTRODUCTION The current market for Cold and Flu Drugs in China is growing rapidly.

  • Influenza
  • China
  • Demand
  • Sanshine Pharmaceutical Co., Ltd.
  • Shineway Pharmaceutical Co., Ltd.

Influenza Market, by Segment, Through 2022 Table ## : European Influenza Market, by Segment, Through 2022 Table ## : Approved WHO Influenza Centers, by Region Table ## : Abbreviations Used in Influenza Markets Table ## : Glossary of Terms Used in

  • Influenza
  • Therapy
  • Vaccine
  • World
  • 5.2 CANADA - INFLUENZA VACCINES MARKET, PERSONS VACCINATED AND
  • 2.2 GLOBAL - NUMBER OF PERSONS VACCINATED WITH INFLUENZA VACCINES AND

Indonesia ##.

  • Influenza
  • World
  • Forecast
  • Market Size
  • Sanofi S.A.

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Influenza
  • Medical Biotechnology
  • Europe
  • Japan
  • Demand

& nbsp; Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Influenza
  • Tuberculosis
  • Europe
  • World
  • Demand

Current scientific views on epidemiology and etiology are provided for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis.

  • Influenza
  • Medical Biotechnology
  • Europe
  • World
  • Demand

Influenza Diagnostics Market Size, Outlook and Growth Opportunities, 2019- 2025 ##.

  • Diagnostics
  • Influenza
  • APAC
  • World
  • Market Size
  • Influenza Vaccines
  • Influenza Drugs

(c) AZOTH Analytics ##.

  • Influenza
  • World
  • Market Size
  • Emergent BioSolutions Inc.
  • Sanofi S.A.
  • INFLUENZA SYMPTOMS
  • INFLUENZA, GENERATING AN OPPORTUNITY FOR

PLOS ONE; ##(##): E##.

  • Influenza
  • Market Size
  • CSL Limited
  • Daiichi Sankyo Company
  • Mitsubishi Corporation

Influenza Diagnostic Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 ##.

  • Diagnostics
  • Influenza
  • APAC
  • World
  • Demand

Seasonal Influenza Vaccines CONTENTS ## FORECAST: SEASONAL INFLUENZA VACCINES (Published on ## January 2019) ## OVERVIEW ## RECENT FORECAST UPDATES ## MARKET OVERVIEW AND TRENDS ## KEY DRIVERS AND RESISTORS OF CONVERSION TO QIVS ## MARKET DEFINITION AND METHODOLOGY ## US MARKET

  • Influenza
  • Pathology
  • Vaccine
  • European Union
  • United States
  • 1.1 INFLUENZA
  • 1.1 INFLUENZA

Pain when one moves eyes.

  • Influenza
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • Sanofi S.A.
  • 5. Influenza Vaccines Brand Sales and Forecast
  • 7. Influenza Vaccines Market - Driving Factors

Mexico ##.

  • Influenza
  • GlaxoSmithKline plc
  • MedImmune, LLC
  • Novartis AG
  • Sanofi S.A.

2019-2024 USA Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2019-2024 USA Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis,

  • Influenza
  • Medical Biotechnology
  • United States
  • Forecast
  • Market Shares

2019-2024 Japan Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2019-2024 Japan Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleo

  • Influenza
  • Medical Biotechnology
  • Japan
  • Forecast
  • Market Shares
  • Previous Flu Seasons in the United States
  • "Must Have" Products for Flu in the US

An estimated one third of American workers get no paid time off when they are sick, so cannot afford to take time off.

  • Influenza
  • Vaccine
  • United States
  • Demand
  • Mondelez International, Inc.

2019-2024 UK Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2019-2024 UK Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, M

  • Influenza
  • Medical Biotechnology
  • United Kingdom
  • Forecast
  • Market Shares

2019-2024 Italy Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2019-2024 Italy Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleo

  • Influenza
  • Medical Biotechnology
  • Italy
  • Forecast
  • Market Shares

2019-2024 Germany Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis 2019-2024 Germany Respiratory Disease Market Shares and Segment Forecasts: Adenovirus, Influenza, Legionella, Mononu

  • Influenza
  • Medical Biotechnology
  • Germany
  • Forecast
  • Market Shares